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The  regulation  of  the  immune  system  in  experimental  animals,  including  the 
production  of immunoglobulin  (Ig) by B cells, is dependent  in large part on interac- 
tions  among  T  cell  subsets,  each  with  its  own  special  function  and  distinguishable 
from other T  cells on the basis of differences in surface antigens  (1). Studies of animal 
models  (2-4)  have led more recently to the discovery of immunoregulatory  networks 
of communicating,  phenotypically  different  T  cells, each providing a  distinct  step in 
a  circuit  leading  to  the  inhibition  of an  immune  response.  Such  circuits  have been 
termed  feedback  suppression  (2,  4)  or  suppressor  amplification  (5).  Germain  and 
Benacerraf  (6)  have  elegantly  synthesized  several  of the  better  known  murine  sup- 
pressor networks  into a  single  major pathway  of T  lymphocyte interactions.  Within 
this synthesis it is possible to distinguish  an Lyt- 1 suppressor-inducer cell that helps in 
the  activation  of  a  precursor  suppressor-amplifier  cell,  (generally  Lyt-l,23)  to  a 
suppressor-amplifier cell, which  in turn activates a  suppressor-effector,  Lyt-23 cell. 
In humans,  the recent production  of monoclonal  antibodies  (7, 8)  to human T  cell 
subsets has enabled the demonstration  that Ig synthesis by B cells is also subject to T 
cell-mediated  regulation  (9-12).  However,  there  have  been  only  limited  studies  of 
immunoregulatory  circuits  in  man  (13-15).  This  report  uses  the  generation  of Ig 
synthesis  in  the  autologous  mixed  leukocyte  reaction  (MLR) 1 to  expand  this  work 
and  provide details of a  suppressor-amplifier circuit. 
The autologous MLR  is generally defined as T  cell proliferation after an autologous 
Ia  +, non-T stimulus  (16). In our hands  (12)  and others  (17), however, the autologous 
MLR  has proved a  useful model to study the regulation of immunoglobulin  synthesis 
in man.  Using previously described  monoclonal  antibodies  (8,  11,  12)  that  allow the 
division  of  peripheral  blood  T  cells  into  nonoverlapping  subsets,  Leu-3  (helper/ 
inducer)  ceils and Leu-2 (suppressor/cytotoxic)  cells, we showed that the induction  of 
Ig synthesis  in  the  autologous  MLR  has  an  absolute  requirement  for  Leu-3  cells, 
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whereas  an  excess of Leu-2  cells suppress the response  (12).  The  current  study was 
undertaken  to  further  assess the immunoregulatory  potential of T  cells activated in 
the autologous MLR. To this end, cells activated in a  primary autologous MLR  were 
separated into subsets using monoclonal antibodies to T  cell markers (8,  11,  12)  and 
HLA-DR  antigen  (18).  The  results demonstrate  that  activated  Leu-2,DR +  T  cells, 
but  neither  Leu-2,DR-  nor  Leu-3 T  cells, can  act  in  a  second autologous MLR  as 
potent, radioresistant suppressor-amplifier cells of Ig synthesis. The activation of this 
subpopulation requires Leu°3 cells in the primary culture; furthermore, in the absence 
of fresh Leu-2 cells in the second culture, little or no suppression was observed. These 
results suggest that at least two distinct subpopulations of Leu-2 cells are required for 
optimum  suppression  of the  immune  response  and  that  immunoregulatory  circuits 
analogous to those described in the mouse  (2-6) exist in man. 
Materials  and  Methods 
Monoclonal Antibodies.  The monoclonal antibodies we used were produced by the method of 
somatic cell hybridization (19).  The T  cell subset monoclonals, anti-Leu-2a and anti-Leu-3a, 
were generously provided by Dr. R. L. Evans, Memorial Sloan-Kettering Cancer Center, New 
York, and have been described previously (8,  11,  12). In the present study, the antibodies were 
used as tissue culture supernatants of cloned cell lines. 
The monoclonal antibodies CA77,  135, 141,206, and BM50, originally prepared by Dr. D. 
J.  Charron  as partially purified ascites fluids (18),  were used  in certain experiments. These 
antibodies, all of which fix complement, are directed against nonpolymorphic determinants of 
HLA-D (Ia) molecules (18) and bind to B lymphocytes, most monocytes, but <3% of normal 
resting peripheral T  cells (20). 
Isolation of  E-rosetting and Nonrosetting Cells  from Peripheral  Blood.  Peripheral blood mononuclear 
leukocytes (PBML) were obtained from normal human volunteers by Ficoll-Hypaque gradient 
centrifugation (21).  Populations enriched for T  and non-T cells were prepared by a single step 
rosetting method (22) using 2-aminoethylisothiouronium bromide hydrobromide (Sigma Chem- 
ical Co.,  St.  Louis, MO)  -treated sheep erythrocytes (SRBC)  and  a  second FicolI-Hypaque 
gradient to separate the rosetted T  cells from the nonrosetted (non-T) cells. The rosetted cells 
were separated from  the SRBC by hypotonic lysis of the latter and  an aliquot  set aside for 
assessment of purity as has been previously described (12). 
Isolatzon of Mononuclear Phagocytes.  After culture in some experiments, plastic-adherent and 
nonadherent cells were separated before panning according to the method of Hausman et al. 
(23).  The  nonadherent  fraction  contained  <1%  alpha  naphthyl  acetate  esterase  (ANAE)- 
positive cells, and the adherent fraction >95% ANAE-positive cells (12). 
Isolation of T Cell Subsets.  Purified subsets of T  cells were obtained by a panning technique 
(24) which permitted the fractionation of fresh or cultured T  cells into Leu-2+/Leu-2  -  or Leu- 
3+/Leu-3  -  subpopulations  (11,  12).  The  purity  of both  positively and  negatively selected 
fractions was tested using indirect immunofluorescence and fluorescence-activated cell sorter 
(FACS) analysis (25).  If anti-Leu-2 was used as the first stage incubating antibody, then <2% 
of the unbound cells were Leu-2  + and >95% of the bound cells were Leu-2  ÷. Similar subset 
purity was achieved when anti-Leu-3 was used as the first stage incubating antibody. In a series 
of preliminary experiments, all separation procedures were carried out with heat-inactivated 
autologous serum instead of fetal calf serum. 
Monoclonal anti-DR, either CA141 or CA206, were used in a similar fashion at a dilution 
of 1:100  to further subdivide Leu-3-  (Leu-2) cells after four washings of the latter. Analysis 
with FACS again confirmed the purity of separated subsets. 
Pretreatment of Cells with  Anti-DR Plus Complement.  In certain experiments, Leu-3  (Leu-2) 
cells were depleted of DR + cells by incubation with a pool of anti-DR monoclonals; CA77, 135, 
141,206, BM50 (18) plus complement as described by Engleman et al. (20). 
Cell  Cultures.  Primary autologous  MLR  were  performed  in  25-cm  2 tissue culture  flasks 
(25100;  Coming Glass Works, Coming,  NY)  in  RPMI  1640 medium supplemented with  25 
mM Hepes buffer, 2 mM glutamine,  100 U/ml penicillin, 100 #g/ml streptomycin, and 20% GATENBY,  KOTZIN,  KANSAS, AND  ENGLEMAN  57 
heat-inactivated autologous or pooled human serum. Each flask contained 10  7 irradiated (2,500 
rad,1:~7Cesium unit; Shepherd JL and Assoc., Glendale, CA) non-T stimulators and 2 ×  107 T 
cell or T  cell subset responders in  15 ml of medium. After a period of culture from 1 to 12 d in 
humidified 10% CO2 in air, the activated T  cells were harvested, various subsets prepared as 
described above, and added to autologous MLR, which were cultured in microwells (12). On 
the day of harvest, cells from several wells were pooled, washed three times in balanced salt 
solution  (BSS), counted, and resuspended in 0.8  ml of BSS in preparation for the assay for 
plaque-forming cells (PFC). 
Protein A PFC Assay.  A polyclonal plaque-forming assay was used to detect IgM- and IgG- 
secreting B cells exactly as has been described by us previously (12). Geometric means and the 
standard deviation of the number of PFC generated by 10  n nonrosetting cells originally placed 
into culture were used to express the data. The percentage of suppression was calculated by the 
formula: (1  -  [(suppressor cells +  control cells)/(control cells alone)]) ×  100. 
Results 
Effect of Actwated Leu-2 Cells on Fresh Autologous  MLR.  Cells were cultured in bulk 
autologous MLR  for 8  d, after which the Leu-2 cells were separated by panning and 
added in the ratios shown  (Fig.  1)  to fresh autologous cultures containing  105 non-T 
cells and  2  ×  105 T  or Leu-3 cells per microwell. In the typical example illustrated 
after a  further 8-d culture,  activated Leu-2 cells added to fresh T  cells at a  ratio of 
1:10  resulted  in  89%  and  78%  suppression  of the  IgM- and  IgG-PFC, respectively; 
and  at  a  ratio  of  1:50,  activated  Leu-2  cells  produced  88%  and  54%  suppression, 
respectively, when  added to cultures containing total T  cells. Also shown  in Fig.  1, 
when  these  same  low  numbers  of  activated  Leu-2  cells  were  added  to  cultures 
containing no fresh Leu-2 cells, no significant suppression was seen. This pattern was 
repeated in eight consecutive experiments with ceils from  five unrelated individuals 
using either autologous or pooled human serum. At ratios of 1 : 1 activated Leu-2 cells 
to fresh Leu-3 cells, ~50-80% suppression of the PFC response was observed (data not 
shown), an effect similar to that  reported previously for fresh autologous Leu-2 cells 
(12).  In contrast, the suppressor effect of the preactivated Leu-2 cells in the presence 
of fresh Leu-2 ceils was at least 50 times more potent than fresh Leu-2 cells alone (12). 
In  experiments  not  shown,  if these  preactivated  Leu-2  cells  were  added  to  fresh 
cultures that had been underway for 72 h, no suppression was seen. 
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FIG.  1.  Suppressive effect of activated Leu-2 cells on  Ig production  in  the autologous  MLR. 
Horizontal axes show the ratio of activated Leu-2 cells to fresh T or Leu-3 cells in culture. Vertical 
columns show the mean and standard deviation of the PFC generated per 10  e non-T cells originally 
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Effect of Leu-3 Cells on the Activation of Leu-2 Suppressor-Amplifier  Cells.  To determine 
if helper T  cells play a role in the activation of Leu-2 suppressor-amplifier cells, bulk 
cultures were initiated with either 2 ×  107 Leu-2 cells and  107 non-T cells per flask or 
2  X  10  7 unseparated T  cells and  107 non-T cells per flask. After 9  d  culture,  in the 
example illustrated (Fig. 2), Leu-2 cells were separated from both types of culture and 
added  to fresh cultures  in  ratios of 1:1,  1:10,  and  1:50,  and  PFC  assayed after 8  d 
microwell  culture.  At  ratios  of  1:1,  both  populations  of preactivated  Leu-2  cells 
resulted in suppression of the PFC response. However, at ratios of 1:10 and 1:50, only 
Leu-2 cells activated in the presence of Leu-3 cells produced suppression of the IgM 
and IgG-PFC. Leu-2 cells obtained from primary cultures that lacked Leu-3 cells were 
no more inhibitory than fresh Leu-2 cells. 
Kinetics  of Activation  or Leu-2  Suppressor-Amplifier  Cells.  To  determine  the  time 
required  for the development of suppressor-amplifier cells, Leu-2 cells were isolated 
after varying periods  of culture  in  autologous MLR and  tested  for the capacity to 
suppress  PFC  induction  in  fresh autologous  MLR  (Fig.  3).  In the example shown, 
little or no suppressor-amplifier activity was detected before 4 d of culture. Maximum 
suppression of both IgM and IgG-PFC developed after 8-10 d of primary culture and 
remained relatively constant thenceforth. 
Kinetics of the Suppressive Effects of Activated Leu-2 Cells.  In the experiments described 
above, PFC were determined at the usual time point of peak response in autologous 
MLR-induced  Ig synthesis  (12).  To assess the  possibility that  activated  Leu-2 cells 
might  alter kinetics  of this  response,  Leu-2  cells were isolated  from 8-d autologous 
MLR and added to fresh microwell cultures containing  105 non-T and 2 ×  l0  b T  or 
Leu-3  cells  per  well  (Fig.  4).  The  results  of IgM-  and  IgG-PFC  generation  show 
suppression of Ig synthesis throughout the second culture period with no evidence of 
altered kinetics of response. By contrast, secondary cultures lacking fresh Leu-2 cells 
were not inhibited by activated Leu-2 cells, regardless of the time of harvest. 
DR Phenotype of the Suppressor-Amplifier  Leu-2 Cells.  T  cells activated with a variety 
of stimuli  have been shown  to express  HLA-DR antigen  (26-28).  After autologous 
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FIG.  3.  Kinetics  of activation  of Leu-2  suppressor-amplifier cells.  The  vertical  axis  shows the 
percent suppression calculated  as described  in Materials and Methods. The horizontal axis is the 
number of days of culture of the primary auto MLR before separation of the activated Leu-2 cells. 
The ratios, h l0 (O) and  1:50 (I-I), are the proportion of activated Leu-2 cells to fresh T  cells in the 
microwell cultures. 
MLR, at least 20% of T  cells from both Leu-2 and Leu-3 subsets are DR positive (C. 
J. Benike and E. G. Engleman, unpublished observations). To determine whether the 
expression  of  DR  antigen  on  activated  Leu-2  cells  correlated  with  suppression, 
Leu-3- cells were  isolated  by panning  from 8-d  autologous  MLR.  After treatment 
with monoclonal anti-DR, these cells were subdivided into Leu-3-, DR  + and Leu-3-, 
DR- cells,  then added  to fresh microwell cultures  in  the ratios shown  (Fig.  5), and 
PFC assayed after 8 d further culture. Although at  1:1 ratios of activated cells to fresh 
cells in  both the  Leu-2, DR  + and  Leu-2, DR-, cells produce suppression  similar to 
that seen in primary cultures (12), at the low ratios of 1:10 and  1:50 the suppressive 
activity was confined to the Leu-2, DR  + fraction. 
As the activated Leu-3- (Leu-2  +) cells could have contained mononuclear phago- 
cytes, these experiments were performed with  a  preadherence step, which  left <1% 
ANAE-positive cells. The purified mononuclear phagocytes were tested in microwell 
cultures  and  showed  no suppressive effects when  2  ×  104 of such  activated macro- 
phages were added  to each well  (data not shown).  Similar results were obtained  in 
four experiments in three different individuals.  Pretreatment of the Leu-2 cells with 
pooled monoclonal anti-DR and complement had no effect on the ability of activated 
Leu-2 cells to suppress PFC generation in a fresh autologous MLR (data not shown). 
Effect of Gamma Irradiation of Preactivated and Fresh Leu-2 Cells.  It was of interest  to 
determine  whether  proliferation  of suppressor-amplifier cells  (Leu-2,  DR  +)  or  the 
suppressor-effector cells (Leu-2, DR-) is required for their respective effects. After 8 d, 60 
400 
300 
200 
100 
0 
~  40G 
300 
2OO 
100 
0 
SUPPRESSOR-AMPLIFIER  CIRCUIT  OF  IMMUNOGLOBULIN SECRETION 
Leu-3 
i  1 
2  4  6  8  10 
DAYS 
IgM 
800 
700 
600 
500 
400 
300 
200 
100 
0 
500 
400 
300 
200 
"i00 
Leu-3 
IgG 
r  '  '  '  ' 
I  i  L  i  L 
2  4  6  8  10 
DAYS 
i 
12 
FIG.  4.  Kinetics of the suppressor effects  of activated  Leu-2 cells. The source of fresh helper cells 
in this experiment is labeled on the four panels of the figure. The horizontal axes show the time in 
days after initiation of the microwell cultures. The vertical axes show the number of PFC per  10  6 
non-T cells originally placed in microwell culture. Each point represents the mean number of PFC 
generated at a given time of harvest. The error bars are omitted for clarity; the standard deviations 
were <15% of the response. Control cultures are indicated  (O). Cultures containing activated  Leu- 
2 cells in a  1  : 10 ratio to either fresh T  or Leu-3 cells are indicated  (I-I). 
bulk culture-activated Leu-2 cells  were separated  by panning, and  2 ×  I04 of these 
cells were added to each well of fresh cultures containing 2 ×  105 Leu-3 cells,  105 Leu- 
2 cells,  and  105 non-T cells  per well.  As shown  in  the  example  (Fig.  6),  either  the 
preactivated Leu-2 cells,  the fresh Leu-2 cells,  or both were irradiated  to  1,500  rad. 
PFC were assayed after 8 d  of culture. The results show that maximum suppression 
is seen when both fresh and preactivated Leu-2 cells were unirradiated. Irradiation of 
the fresh Leu-2 cells  removed suppression, but irradiation of the preactivated Leu-2 
cells  alone  had  little  or  no  effect  on  suppression.  Irradiation  of both  Leu-2  sets 
completely ablated suppression. 
Effect of Preactivated Leu-3 Cells on Fresh Autologous MLR.  In a  series  of preliminary 
experiments,  it  was  observed  that  preactivated  Leu-3  cells,  when  added  to  fresh 
autologous MLR, lead to a  reduction in the usual peak of Ig synthesis. To examine 
the  possibility  that  the  addition  of activated  Leu-3  cells  may  alter  the  time  or 
magnitude of the  peak  PFC  response,  a  kinetic study was performed.  T  cells were 
activated in primary flask cultures, and the Leu-3 cells were separated after 8 d. These 
cells  were. added  in  the  ratios  shown  (Fig.  7)  to fresh  autologous MLR containing 
2 ×  105 T  or Leu-3 cells  and  10  ~ non-T cells  per well.  In the typical case illustrated, 
preactivated Leu-3 cells lead to an earlier and in some cases higher peak oflg synthesis GATENBY,  KOTZIN,  KANSAS,  AND  ENGLEMAN 
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followed  by  a  fall  with  apparent  suppression  of  the  PFC  response  by  the  time 
maximum antibody synthesis was reached in control cultures. This same pattern was 
seen in four different individuals. 
Discussion 
The autologous MLR has proved a useful reaction in studies of immunoregulation 
in  man,  and  although  its  physiological  role remains  uncertain,  it  demonstrates  the 
typical attributes of an immune response, memory, and specificity  (16). In this study, 
the use of a  double culture system, whereby T  cells or T  cell subsets are preactivated 
in  autologous MLR  and then tested  in a  second autologous MLR,  has allowed  the 
characterization of cells involved in an immunoregulatory circuit in man. The schema 
illustrated  in Fig.  8  demonstrates the cells that  have been defined  and their surface 
phenotypes  characterized so  far.  Thus,  we have produced  evidence  of a  Leu-3  cell 
necessary for the activation of a Leu-2 cell, which initiates the suppressor circuit  (Fig. 
2).  This cell  can  be  designated  a  suppressor-inducer cell  and appears  to subserve a 
similar function to an Lyt-1  cell described in various antigen-specific  murine systems 
(2-6).  Previous results from other groups using pokeweed mitogen  (PWM)  (10)  and 
antigen-driven (14) systems in humans have produced evidence of the need for helper 
T  cells to induce suppressor activity within the reciprocal suppressor population. We 
have previously shown that  Leu-2  cells  alone react  poorly in the autologous MLR, 
and it is not surprising that Leu-3 cells are required for the activation of Leu-2 cells; 
indeed, in the presence of Leu-3 cells, Leu-2 cells proliferate quite adequately  (I 1). 62  SUPPRESSOR-AMPLIFIER  CIRCUIT  OF  IMMUNOGLOBULIN  SECRETION 
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FIG.  6.  Effect of gamma irradiation on activated suppressor-amplifier  and fresh suppressor-effector 
Leu-2 cells. On the left, adjacent to each column, are the number of preactivated Leu-2 cells and 
fresh Leu-2 cells in each microwell of the second culture. The columns represent the mean number 
of PFC and standard deviation generated in each group per  l0  ~ non-T cells originally placed  in 
microweil culture (R =  1,500  rad). 
The suppressor-amplifier precursor cell defined in these experiments  (Fig. 8)  bears 
the  Leu-2  phenotype,  but  is  negative  for  DR  antigens  as  defined  by  the  pool  of 
monoclonal antibodies used in this study. This cell appears analogous to the murine 
suppressor-amplifier  precursor as summarized by  Germain  and Benacerraf (6).  The 
suppressor-amplifier cell  characterized in these experiments  resembles the feedback- 
suppressor cell  defined  in the mouse (2-6).  The cell  has the phenotype Leu-2,  DR + 
(Fig. 5)  and demonstrates a potent, radioresistant recruiting effect on fresh Leu-2 cells 
(Figs.  1,  6),  which  it  can  presumably  perform  without  the  need  to  undergo  cell 
division.  Within  the fresh Leu-2 population, however, the radiosensitive suppressor- 
effector cells appear to have to undergo cell division to exert their optimum effect. 
The  suppressor-amplifier  cell  appears  to arise  from an  initially  DR-negative  cell 
population  and  develops  DR  antigens  on its  surface  as  it  becomes activated.  Such 
optimal activation indeed takes 8-10  d  (Fig.  3), a  period during which DR antigens 
may appear on the surface of an originally negative population. The development of 
Ia or DR antigens on the surface ofT cells has been associated with the expression of 
specific function, including the ability to generate helper activity for Ig synthesis (29) 
and  to  suppress  proliferation  induced  by  alloantigens  (28)  or  mitogens  (30).  The 
presence of Ia or DR antigens on a  cell  involved in suppression is in contrast to the 
absence of Ia on human cytotoxic T  cells  (31). 
The  third  cell  in  this  feedback-suppressor  network is  a  Leu-2  suppressor-effector 
cell,  which  acts  to  inhibit  the  generation  of antibody-forming  cells  (Fig.  6).  The c9 
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sensitivity  of this cell to gamma irradiation  suggests that  it has to divide,  as we have 
previously  demonstrated  (12)  for  Leu-2-mediated  suppression  of Ig synthesis  in  the 
primary  autologous  MLR.  However,  although  division  must  occur,  the  combined 
inhibitor  effect  of the  amplifier  and  effeetor-suppressor  cells  on  PFC  generation  in 
fresh  autologous  MLR  is  detected  as soon as 4  d  after  initiation  of culture  (Fig.  3), 
suggesting  that  early cellular  interactions  determine  the suppressed  state.  This inter- 
pretation  is  supported  by  the  observation  that  addition  of activated  Leu-2  cells  to 
3-d-old cultures  fails to suppress Ig synthesis. 64  SUPPRESSOR-AMPLIFIER CIRCUIT OF IMMUNOGLOBULIN SECRETION 
I  B CELL  I  ~+~---~  ~\J 
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FIo. 8.  Schema of the immunoregulatory  interactions investigated in this study. -->+ or -  indicate 
putative positive and negative signals, respectively. ---+ indicates a step which may represent the 
action of one cell type upon another, or the maturation of one cell type into the other. The surface 
phenotype defined is marked on each cell type. The events envisaged occurring in the first culture 
are shown above, those in the second culture, below. 
This  suppressor-effector  cell  described  here  again  shows  analogy  to  the  Lyt-23 
suppressor-effector cell of murine systems (2-6). In summary, therefore, these experi- 
ments have produced evidence for Leu-3-dependent activation of a  Leu-2 suppressor- 
amplifier precursor cell, which once activated expresses DR antigen, and although at 
low cell numbers  it exerts little or no suppression itself, can act as a  potent radiore- 
sistant suppressor-amplifier cell that can activate fresh Leu-2 suppressor-effector cells 
to inhibit Ig synthesis generated in an autologous MLR. 
Initial studies of the effects of precultured Leu-3 cells on the generation of PFC in 
the  autologous  MLR  suggested  that  these  cells  also  exerted  an  inhibitory  effect. 
However,  kinetic  analysis  of  the  Leu-3  effect  demonstrated  an  early  peak  of  Ig 
synthesis followed by a  fall below the peak response of the controls. This effect was 
seen even  in  experiments  in  which  there were  no  Leu-2  cells present  in  the second 
micrawell culture.  Although a  suppressor mechanism  cannot  be formally ruled out, 
the effect seen could have a simple kinetic explanation with consumption of important 
factors or nutrients concomitant with the early peak of Ig synthesis in the cultures to 
which  preactivated Leu-3 ceils were added.  Suppression by activated cells of helper 
phenotype (10)  has been described in a  PWM-driven stimulation of Ig synthesis (13, 
32).  Although the system used in these studies and  the generation of Ig synthesis in 
the autologous MLR  described here are not strictly comparable, it is significant that 
no kinetic studies were reported (13, 32). 
The  experiments  reported  here  raise  the  question  of further  definition  of abnor- 
malities of the autologous MLR in disease. The proliferative response to an autologous 
non-T  stimulus  is  defective  in  NZB/W  mice,  a  murine  model  for  systemic  lupus 
erythematosus, as well as several other strains associated with autoimmune syndromes 
(33).  In  the  NZB/W  mouse  model,  there  is a  deficiency of feedback suppressor,  or GATENBY, KOTZIN, KANSAS, AND ENGLEMAN  65 
suppressor-amplifie  r  cells  (33).  Additional  studies  of the  generation  of suppressor- 
amplifier cells in the autologous MLR of patients with systemic lupus erythematosus, 
a  disease  in which a  defective autologous MLR has been  reported  (34,  35), and  in 
other autoimmune diseases should help shed light upon the details of their immune 
abnormalities. 
Summary 
The  induction of immunoglobulin  (Ig)  synthesis  in  the autologous MLR has  an 
absolute  requirement  for helper/inducer  (Leu-3)  T  cells,  whereas an  excess  of sup- 
pressor/cytotoxic  (Leu-2)  cells  suppresses  the  response.  The  current  study  was  an 
effort to assess the immunoregulatory potential of T  cells activated in the autologous 
mixed-leukocyte response (MLR). T  cells were cultured with autologous non-T cells 
for  8-9  d,  after  which  the  activated  T  cells  were  fractionated  into  subsets  with 
monoclonal antibodies to T  cell markers and HLA-DR antigen. Each population was 
co-cultured in fresh autologous MLR, and on the 8th day of culture, Ig-secreting cells 
were measured in a  reverse hemolytic plaque assay. The results show that activated 
Leu-2, DR  + T  cells,  but neither Leu-2, DR- nor Leu-3 T  cells, were at least 50 times 
more potent as suppressors of IgM and IgG synthesis than fresh Leu-2 cells alone. The 
activation  of this  Leu-2,  DR  + subpopulation  required  Leu-3  cells  in  the  primary 
culture.  Furthermore, in the absence of Leu-2 cells  in the second culture, little or no 
suppression  was  observed,  suggesting that  the  Leu-2,  DR  + cells  act  to  amplify or 
induce suppressor effects of fresh Leu-2 cells. This indicates that at least two distinct 
subpopulations of Leu-2 cells are  required  for maximal suppression  of an  immune 
response,  and  that  immunoregulatory circuits  analogous to  those  described  in  the 
mouse exist in man. 
We thank  Lindsay Gatenby for preparation  of the  manuscript,  Andrew  Benn  for technical 
assistance, and Claudia Benike for her advice with the manuscript. 
Received  for publication 17 February t982 and in revised  forra 5 April  1982. 
References 
1.  Cantor, H., and E. A. Boyse. 1977. Regulation  of cellular and humoral immunity by T cell 
subclasses. Cold Spring Harbor Syrnp. Quant. BioL 41:23. 
2.  McDougal,  J.  S.,  F.  W.  Shen,  S.  P.  Cort,  and  J.  Bard.  1980. Feedback  suppression: 
phenotypes ofT cell subsets involved in the Ly 1 T cell-induced immunoregulatory circuit. 
J. Immunol. 125:1157. 
3.  Tada, T., and K.  Hayakawa.  1980. Antigen  specific helper  and suppressor  factors. Prog. 
ImmunoL 4:389. 
4.  Eardley, D. D. 1980. Feedback suppression: an immunoregulatory circuit. Fed. Proc. 39:3114. 
5.  Gershon,  R.  K.  1980. Immunoregulation circa  1980: Some comments on the state  of the 
art.J. Allergy Clin. Immunot. 66:t8. 
6.  Germain,  R.  N.,  and  B.  Benaeerraf.  1981. A  single  major  pathway  of T-lymphocyte 
interactions  in antigen specific immune suppression. Scand. J. ImmunoL 13:1. 
7.  Kung,  P.  C.,  G.  Goldstein,  E.  L.  Reinherz,  and  S.  F.  Schlossman.  1979. Monoclonal 
antibodies  defining  distinctive  human  T  cell surface  antigens.  Science (Wash.  D.  C.). 
206:347. 
8.  Evans, R. L., D. W. Wall, C. D. Platsoueas, F. P. Siegal, S. M. Fikrig, C. M. Testa, and R. 66  SUPPRESSOR-AMPLIFIER CIRCUIT OF IMMUNOGLOBULIN SECRETION 
A. Good. 1981. Thymus-dependent membrane antigens in man: Inhibition of cell-mediated 
lympholysis by monoclonal antibodies to TH2 antigen. Proc. Natl.  Acad. Sci.  U. S. A. 78:544. 
9.  Reinherz, E. L., and S. F. Schlossman. 1980. The differentiation and function of human T 
lymphocytes. Cell, 19:821. 
10.  Thomas, Y., J.  Sosman, O. Irigoyen, S. M. Friedman, P. C. Kung, G. Goldstein, and L. 
Chess. 1980. Functional analysis of human T cell subsets defined by monoclonal antibodies. 
I.  Collaborative T-T  interactions in  the  immunoregulation  of B  cell differentiation. J. 
Immunol.  125:2402. 
11.  Engleman, E. G., C. J. Benike, F. C. Grumet, and R. L. Evans.  1981. Activation of human 
T  lymphocyte subsets: helper and suppressor/cytotoxic T  cells recognize and respond to 
distinct histocompatibility antigens.J. Immunol.  127:2124. 
12.  Gatenby, P. A., B. L. Kotzin, and E. G. Engleman.  1981. Induction of immunoglobulin 
secreting cells in the human autologous mixed leukocytes reaction: Regulation by helper 
and  suppressor  lymphocyte  subsets  defined  with  monoclonal  antibodies. J.  Immunol. 
127:2130. 
13.  Thomas, Y., L. Rogozinski, O. H. Irigoyen, S. M. Friedman, P. C. Kung, G. Goldstein, and 
L.  Chess.  1981. Functional  analysis  of human  T  cell  subsets  defined  by  monoclonal 
antibodies. IV. Induction of suppressor cells within the OKT4 + population. J.  Exp.  Med. 
154:459. 
14.  Morimoto,  C.,  E.  L.  Reinherz,  Y.  Borel,  E.  Mantzouranis,  A.  D.  Steinberg, and  S.  F. 
Schlossman.  1981. Autoantibody to an immunoregulatory inducer population in patients 
with juvenile rheumatoid arthritis.J. Clin. Invest. 67:753. 
15.  Benike,  C.  J.,  R.  L.  Evans,  and  E.  G.  Engleman.  1981. Antigen  specific  feed-back 
suppression of the mixed lymphocyte reaction. Hum. Immunol. 3:353 
16.  Weksler, M. E., C. E. Moody, and R. W. Kozak. 1981. The autologous mixed lymphocyte 
reaction. Adv. Immunol. 31:271. 
17.  Yu, D. T. Y., N. Chiorazzi, and H. G. Kunkel. 1980. Helper factors derived from autologous 
mixed lymphocytes cultures. Cell. Immunol. 50:305. 
18.  Charron, D. J., C. Benike, E. G. Engleman, and H. O. McDevitt. 1979. Human lymphocyte 
subpopulations: studies with monoclonal anti-Ia antibodies. Blood. 54:177. 
19.  Kohler, G., and C. Milstein. 1976. Continuous culture of fused cells secreting antibody of 
predefined specificity. Nature  (Lond.). 250:495. 
20.  Engleman,  E.  G., D. J.  Charron,  C. J.  Benike, and  G. J.  Stewart.  1980. Ia antigen  on 
peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function 
of HLA-DR antigen on non-T cells.J. Exp. Med.  152:99s. 
21.  Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand 
J.  Clin. Lab. Invest. 21(Suppl. 97):77. 
22.  Saxon, A., J. Feldhaus, and R. A. Robins. 1976. Single step separation of human T  and B 
cells using AET treated sheep red cells. J. Immunol. Methods.  12:285: 
23.  Hausman, P. B., H. V. Raft, R. C. Gilbert, L. J. Picker, andJ. D. Stobo. 1980. T  cells and 
macrophages involved in the autologous mixed lymphocyte reaction are required for the 
response to conventional antigen. J. Immunol. 125:1374. 
24.  Wysocki, L. J.,  aand  V.  L.  Sato.  1978. "Panning"  for  lymphocytes: A  method  for cell 
selection. Proc. Natl.  Acad. Sci. U. S. A. 75:2844. 
25.  Herzenberg,  L.  A.,  and  L.  A.  Herzenberg.  1978. Analysis  and  separation  using  the 
fluorescence activated cell sorter (FACS). In Handbook of Experimental Immunology, 3rd 
edition. D. M. Weir, editor. Blackwell Scientific Publications, Oxford. 22:1. 
26.  Evans,  R.  L.,  T. J.  Faldetta,  R.  E.  Humphreys,  D.  M.  Pratt,  E. J.  Yunis,  and  S.  F. 
Schlossman. 1978. Peripheral human T cells sensitized in mixed leukocyte culture synthesize 
and express Ia-like antigens.J. Exp. Med.  148:1440. 
27.  Ko,  H.  S.,  S.  M.  Fu,  R.  J.  Winchester,  D.  T.  Y.  Yu,  and  H.  G.  Kunkel.  1979. Ia GATENBY,  KOTZIN,  KANSAS, AND ENGLEMAN  67 
determinants on stimulated human T  cells. Occurrence on mitogen and antigen activated 
T  cells.J. Exp. Med. 150:246. 
28.  Engleman, E. G., C. J.  Benike, and D. J. Charron.  1980. Ia antigen on peripheral blood 
mononuclear leukocytes in man. II. Functional studies of HLA-DR positive T cells activated 
in mixed lymphocyte reactions. J. Exp. Med. 152:114s. 
29.  Fu, S. M., N. Chiorazzi, C. Y. Wang, G. Montazeri, H. G. Kunkel, H. S. Ko, and A. B. 
Gottlieb.  1978. Ia-bearing T  lymphocytes in  man.  Their identification and  role  in  the 
generation of allogeneic helper activity.  J. Exp. Med. 148:1423. 
30.  Fainboim, L., C. Navarrete, and H. Festenstein.  1980. Precursor and effector phenotypes 
of activated human T  lymphocytes. Nature (Lond.).  288:391. 
31.  Reinherz, E.  L., R.  E.  Hussey, and  S. F. Schlossman.  1980. Absence of expression of la 
antigen on human cytotoxic T  cells. Immunogenetics. 11:421. 
32.  Yachie,  A.,  T.  Miyawaki,  T.  Nagaoki,  Y.  Tohru,  M.  Mukai,  N.  Uwadana,  and  N. 
Taniguchi.  1981. Regulation  of B  cell  differentiation  by  T  cell  subsets  defined  with 
monoelonal OKT4 and OKT8 antibodies in human cord blood..]. Immunol. 127:1314. 
33.  Smith, J.  B., and R. D. Pasternak.  1978.  Syngeneic mixed lymphocyte reaction in mice: 
strain  distribution,  kinetics,  participating cells and  absence  in  NZB  mice. J.  Immunol. 
121:1889. 
34.  Sakane, T., A. D. Steinberg, and I. Green.  1978. Failure of autologous mixed lymphocyte 
reactions between T  and non-T cells in patients with systemic lupus erythematosus. Proc. 
NatL Acad. Sci. U. S. A. 75:3464. 
35.  Kuntz,  M.  M., J.  B.  Innes, and M.  E. Weksler.  1979. The cellular basis of the impaired 
autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. J. 
Clin. Invest. 63:151. 